Quoin Pharmaceuticals Ltd.
13F holders, Q3 2024 (September 30)7holders −3
2new positions
5sold out
1famous investor
$0.50avg. 13F price*
At the end of Q3 2024, 7 institutions reported holding Quoin Pharmaceuticals Ltd. in their 13F filings, down 3 from Q2 2024. 2 opened new positions and 5 sold out. The largest holders were Renaissance Technologies ($19K), Two Sigma Securities, LLC ($16K) and Virtu Financial LLC ($13K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Quoin Pharmaceuticals Ltd.
- CUSIP
- 74907L300
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $25K |
| Exits | 5 | $82K |
All 13F filers, Q2 2024 → Q3 2024: 85,888 shares bought and 140,880 shares sold, net −54,992 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Renaissance Technologies | 0.00% | Add +13.1% | 38,691 | $19K |
| Two Sigma Securities, LLC | 0.00% | Add +35.8% | 31,854 | $16K |
| Virtu Financial LLC | 0.00% | New | 25,165 | $13K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | New | 25,119 | $12K |
| UBS Group AG | 0.00% | Add +274.3% | 22,821 | $11K |
| Rhumbline Advisers | 0.00% | Add +40.5% | 20,786 | $10K |
| JPMorgan Chase & Co. | 0.00% | No change | 645 | $326 |
"% of holder's portfolio" is QUOIN PHARMACEUTICALS LTD's weight in each manager's 13F, not the share of Quoin Pharmaceuticals Ltd. the manager owns.